Glycogen storage disease type II classification: Difference between revisions
No edit summary |
|||
Line 34: | Line 34: | ||
==Classification== | ==Classification== | ||
{| | |||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Type of GDS 2}} | |||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Age of onset}} | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |'''Infantile-onset Pompe disease (IOPD)''' | |||
| style="background: #F5F5F5;" |Age of onset before 12 months with cardiomyopathy | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |'''Late-onset Pompe disease (LOPD)''' | |||
| style="background: #F5F5F5;" | | |||
*Age of onset before 12 months without cardiomyopathy | |||
*Age of onset after 12 months | |||
|} | |||
* | |||
* | |||
==References== | ==References== |
Revision as of 19:14, 8 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II classification On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II classification |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
Type of GDS 2 | Age of onset |
---|---|
Infantile-onset Pompe disease (IOPD) | Age of onset before 12 months with cardiomyopathy |
Late-onset Pompe disease (LOPD) |
|